SCHEMBL30786135

SCHEMBL30786135

O=C(NC1CC1)c1cccc(F)c1Sc1ccc2c(/C=C/c3cccc(CCCN4CCCC4)n3)nn(C3CCCCO3)c2c1

nearest known ligand 0.35

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.35
DRD4 P21917 2/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CNR1 P21554 6/20 0.31
CNR2 P34972 6/20 0.31
RAD52 P43351 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
BMPR1B O00238 1/20 0.30
BMPR1A P36894 1/20 0.30
TGFBR1 P36897 1/20 0.30
ACVRL1 P37023 1/20 0.30
ACVR1 Q04771 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30786156 0.96 KDR (0.35) KDRDRD4MEN1KMT2ACNR1
SCHEMBL30786190 0.91 KDR (0.44) KDRDRD4MEN1KMT2ACNR1
SCHEMBL30786236 0.90 KDR (0.37) KDRDRD4MEN1KMT2ACNR1
SCHEMBL30786078 0.89 KDR (0.36) KDRDRD4CNR1CNR2BMPR1B
SCHEMBL30786128 0.89 CNR1 (0.31) CNR1CNR2
SCHEMBL30786153 0.86 KDR (0.36) KDRDRD4KMT2A
SCHEMBL31475235 0.85 KDR (0.46) KDRDRD4MEN1KMT2ACNR1
SCHEMBL30786208 0.84 KDR (0.38) KDRCNR1CNR2
SCHEMBL31475216 0.82 DRD2 (0.33) KDR
SCHEMBL30786152 0.80 KDR (0.35) KDRCNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025082316-A1 OPHTHALMIC FORMATION, AND PREPARATION METHOD THEREFOR AND USE THEREOF 苏州必扬医药科技有限公司 2025-04-24 WO disclosed
CN-119604488-A Protein tyrosine kinase inhibitor and medical application thereof 苏州必扬医药科技有限公司 2025-03-11 CN disclosed
WO-2024032584-A1 PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOF 苏州必扬医药科技有限公司 2024-02-15 WO disclosed